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Post-mitotic neurons must have strong antioxidant defenses 
to survive the lifespan of the organism. We recently showed that 
neuronal antioxidant defenses are boosted by synaptic activity. 
Elevated synaptic activity, acting via the N-methyl-D-aspartate 
(NMDA) receptor, enhances thioredoxin activity, facilitates the 
reduction of hyperoxidized peroxiredoxins, and promotes resis-
tance to oxidative stress. In contrast, blockade of spontaneous 
synaptic NMDA receptor activity renders neurons highly sensi-
tive  to  hyperoxidation  of  peroxiredoxins  by  oxidative  insults. 
These NMDA receptor-dependent effects are mediated in part 
by a coordinated program of gene expression changes centered 
on  the  thioredoxin-peroxiredoxin  system,  a  thiol-based  enzy-
matic system which is an important reducer of oxidative stressors 
such  as  hydroperoxides.  We  show  here  that  while  too  little 
glutamatergic activity can render neurons vulnerable to peroxire-
doxin hyperoxidation, so can too much. Exposure of neurons to 
toxic concentrations of glutamate, activating both synaptic and 
extrasynaptic  NMDA  receptors,  acutely  induces  peroxiredoxin 
hyperoxidation.  Thus,  the  effect  of  NMDA  receptor  activity 
on the activity of neuronal peroxiredoxins follows the classical 
U-shaped dose response curve.
Introduction
Correct redox regulation is essential in all cells, especially in 
post-mitotic cells such as neurons where harmful oxidative damage 
can accumulate. Oxidative damage and stress occurs when there is 
an imbalance between production of reactive oxygen species (ROS) 
and  the  cell’s  capacity  to  neutralize  them  through  its  intrinsic 
antioxidant  defenses.  Neurons  are  particularly  susceptible  to 
oxidative damage due to high levels of ROS production (through 
respiration and metabolism) and relatively low levels of certain 
antioxidant  enzymes,  particularly  catalase.1,2  Oxidative  damage 
is  implicated  in  the  pathogenesis  of  several  neurodegenerative 
diseases as well as acute cerebrovascular disorders.1,2 Appropriate 
redox balance depends on the activity of antioxidant systems. Key 
among these are the thiol reducing systems based round thiore-
doxin and glutathione respectively, which are important reducers 
of  many  oxidative  stressors  such  as  peroxides.2,3 The  principle 
source of peroxide is from spontaneous and superoxide dismutase 
(SOD)-catalysed  dismutation  of  superoxide  generated  in  active 
mitochondria. However, other sources of peroxides exist, including 
products  of  metabolic  pathways  involving  oxidases/oxygenases 
(e.g., monoamine oxidase).
We  recently  showed  that  the  vulnerability  of  neurons  to 
oxidative death triggered by exposure to hydrogen peroxide was 
regulated  by  synaptic  activity  acting  via  N-methyl-D-aspartate 
(NMDA)  receptor  (NMDAR)  signaling.4  Neurons  that  were 
experiencing (or had recently experienced) higher levels of synaptic 
NMDAR activity were far more likely to withstand the oxidative 
insult  than  electrically  quiet  neurons.  Accumulation  of  reactive 
oxygen  species  following  an  oxidative  insult  was  significantly 
lower in active neurons than inactive ones. Neurons experiencing 
complete NMDAR blockade were highly vulnerable to peroxide-
induced  apoptosis  in  vitro,  and  NMDAR  blockade  in  vivo 
promoted neuronal apoptosis associated with oxidative damage. 
It is not completely clear why synaptic activity, acting via Ca2+ 
signaling, should act to boost antioxidant defences. One possibility 
is to protect against increased ROS generation associated with high 
energy demand. Synaptic activity and activity-dependent plasticity 
place high energy demands on a neuron which must be largely met 
through oxidative phosphorylation, a process that generates ROS. 
Thus, active neurons would ordinarily need to have stronger anti-
oxidant defenses than inactive ones in order to maintain the correct 
redox balance. However, synaptic activity is clearly strengthening 
antioxidant defenses above and beyond that required to cope with 
increased metabolic activity, since active neurons become resistant 
to additional exogenous insults.4
Investigations  into  the  mechanism  behind  this  revealed  that 
synaptic activity exerted a number of changes to the thioredoxin-
peroxiredoxin system which contributed to the activity-dependent 
protection.4 Synaptic activity enhanced thioredoxin activity and 
facilitated  the  reduction  of  hyperoxidized  peroxiredoxins,  an 
important  class  of  antioxidant  enzymes.  These  changes  were 
  mediated by a coordinated program of gene expression changes. 
Synaptic NMDAR activity triggered the transcriptional suppres-
sion  of  the  thioredoxin  inhibitor  Txnip,  a  protein  known  to 
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enhance  oxidative  stress.  Furthermore,  enhanced  reduction  of 
hyperoxidized peroxiredoxins was associated with transcriptional 
induction of two genes, sulfiredoxin and sestrin 2, whose products 
are reported to mediate this reaction. We did not address which 
of sestrin 2 or sulfiredoxin was responsible for reducing peroxire-
doxin hyperoxidation. However, we recently showed that specific 
induction  of  sulfiredoxin  is  sufficient  to  prevent  peroxiredoxin 
hyperoxidation  in  neurons.5  In  any  case,  induction  of  one  (or 
both) of these genes cooperated with the suppression of Txnip in 
boosting antioxidant defenses.
The effect of synaptic NMDAR activity in promoting the reduc-
tion of hyperoxidized peroxiredoxins may at first glance appear to 
be at odds with other studies that report the induction of oxidative 
stress and free radical production by NMDAR activity. For example, 
NMDAR activity has been shown to induce superoxide produc-
tion using electron spin resonance detection.6 Indeed, agonists of 
all ionotropic glutamate receptors, as well as glutamate itself can 
induce  rapid  ROS  generation.7,8  However,  the  ROS-generating 
capacity  of  agonists  of  ionotropic  glutamate  receptors  are  typi-
cally  studied  in  the  context  of  excitotoxic  levels  of  agonists. 
Increased free radical production is likely a result of consequences 
of excessive Ca2+ influx, such as intracellular Ca2+ deregulation or 
mitochondrial dysfunction as well as other processes such as strong 
activation of nitric oxide production.9,10 In contrast, our stimula-
tion paradigms used to promote synaptic activity are not toxic, 
quite the reverse-they are neuroprotective.11-13 Moreover, they do 
not induce mitochondrial dysfunction.11 The response of neurons 
to NMDAR activity follows an inverted U-shaped, or bell shaped 
curve, i.e., too much or too little can be potentially harmful.14,15 
The studies which report ROS generation are generally concerned 
with the effect of high toxic levels of NMDAR activity, while we 
are looking at the central part of the curve where modest levels of 
NMDAR activity are protective.
Results
To contrast the effects of synaptic activity with those of toxic 
doses  of  glutamate,  we  have  studied  peroxiredoxin  hyperoxida-
tion in response to excitotoxic concentrations of glutamate (20 
and  40  μM).  Glutamate  was  added  in  the  presence  of  tetro-
dotoxin  to  prevent  preferential  activation  of  synaptic  NMDA 
receptors  (which  can  happen  in  its  absence16).  We  observed  a 
significant elevation of levels of peroxiredoxin hyperoxidation at 
two hours post-treatment (Fig. 1A), indicative of oxidative stress. 
In  contrast,  stimulating  synaptic  activity  using  an  established 
model (bicuculline plus 4-aminopyridine (BiC/4-AP)13,17) triggers 
no peroxiredoxin hyperoxidation at any time point observed (Fig. 
1B). This emphasizes the difference between the two stimulation 
paradigms.
It is worth noting that the difference between these two stimu-
lation paradigms is not simply due to degree of NMDA receptor 
activity. If this was true then exposure of neurons to lower doses 
of glutamate (e.g., 5 and 10 μM) would trigger the same effects 
as BiC/4-AP treatment. However, these stimuli do not trigger the 
same anti-oxidative effects: reduction of peroxiredoxin hyperoxida-
tion or sulfiredoxin/sestrin 2 upregulation is not promoted, nor is 
protection against oxidative stress.4 The key difference is that the 
strong antioxidative signaling described in4 relies on the trans-syn-
aptic activation of synaptic NMDA receptors. Chronic activation 
of all (synaptic and extrasynaptic NMDA receptors) is unable to 
recapitulate trans-synaptically evoked signaling, regardless of dose. 
It is currently unclear how synaptic and extrasynaptic NMDARs 
would be coupled to different signaling pathways in the context of 
the effects described here. It could be that they are coupled differ-
ently (either physically or functionally) as a result of their differing 
location. Another contributing factor could be the way in which 
these distinct pools are activated: brief saturating activation in the 
case of trans-synaptic activation of synaptic NMDARs vs. chronic 
Neuronal oxidative damage by excessive glutamate exposure
Figure 1. Excitotoxic glutamatergic activity promotes hyperoxidation of peroxiredoxins. (A and B) Lower: Example western analysis of peroxiredoxin (Prx) 
hyperoxidation in neurons treated as indicated, using an anti-PrxSO2/3H specific antibody. Upper: densitometric analysis of PrxSO2/3H band intensity 
of Prx II, normalized to the appropriate Prx II band. *p < 0.05 compared to control (1-way Anova followed by Fisher’s LSD test, n = 5).Neuronal oxidative damage by excessive glutamate exposure
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Concluding Remarks and Future Perspectives
The  detailed  activity-dependent  changes  in  gene  expression 
which contribute to enhanced antioxidant defenses have hitherto 
focused on the thioredoxin system.4 However, these changes do 
not account for the full effects of synaptic activity, suggesting that 
other enzymic systems may also be targeted. It will be of interest to 
know how, or whether, synaptic activity boosts the capacity of the 
other key antioxidant system in neurons-that based on   glutathione. 
Another outstanding issue is the degree to which protective changes 
in gene expression occur in vivo following an episode of NMDA 
receptor activity. Given that an episode of ischemia/reperfusion 
triggers hyperoxidation of peroxiredoxins,4 one might expect that 
a protective preconditioning episode reduces this. If this is indeed 
the case, this would beg the question as to whether the changes in 
gene expression, such as upregulation of the peroxiredoxin regener-
ating enzyme, sulfiredoxin, occur in response to preconditioning.
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low level activation of extrasynaptic NMDARs by bath/ambient 
glutamate. Differences in the properties of intracellular Ca2+ tran-
sients evoked by these different stimuli could differentially affect 
signaling, even if the overall Ca2+ load were similar (reviewed in 
ref. 18).
The observation that exogenous glutamate exposure induced 
hyperoxidation  of  peroxiredoxins  is  interesting  in  view  of  the 
fact that this event also occurs in vivo following an excitotoxic 
  insult-namely  ischemia  followed  by  reperfusion.4  Thus,  it  is 
possible  that  ROS  generation  triggered  by  excessive  glutamate 
build up following an ischemic episode contributes to neuronal 
damage through inactivation of peroxiredoxins, in concert with the 
many other damaging events that take place, such as stress-activated 
protein kinase activation, calpain activation, nitric oxide produc-
tion as well as inflammatory events and ionic imbalance.19-24
Materials and Methods
Neuronal cultures and stimulation. Cortical rat neurons were 
cultured as described25 from E21 rats except that growth medium 
was supplemented with B27 (Invitrogen). Stimulations were done 
in both cases after a culturing period of 8–10 days during which 
cortical neurons develop a network of processes, express functional 
NMDA-type  and  AMPA/kainate-type  glutamate  receptors,  and 
form synaptic contacts. Stimulations were performed after trans-
ferring  neurons  into  defined  medium  lacking  trophic  support 
“TMo”:13  10%  MEM  (Invitrogen),  90%  Salt-Glucose-Glycine 
(SGG)  medium;26  (SGG:  114  mM  NaCl,  0.219%  NaHCO3, 
5.292 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES, 1 
mM Glycine, 30 mM Glucose, 0.5 mM sodium pyruvate, 0.1% 
Phenol Red; osmolarity 325 mosm/l, hereafter TMo). Bursts of 
action potential firing were induced by treatment of neurons with 
50 μM bicuculline, and burst frequency was enhanced by addition 
of 250 μM 4-amino pyridine.27 Glutamate was applied at the indi-
cated concentration in the presence of TTX (2 μM, Tocris).
Western blotting and antibodies. Total cell lysates were boiled 
at 100°C for 5 min in 1.5x sample buffer (1.5 M Tris pH 6.8; 
Glycerol 15%; SDS 3%; β-mercaptoethanol 7.5%; bromophenol 
blue  0.0375%).  Gel  electrophoresis  and  western  blotting  were 
performed using Xcell Surelock system (Invitrogen) using precast 
gradient gels (4–20%) according to the manufacturer’s instruc-
tions. The gels were blotted onto PVDF membranes, which were 
then blocked for one hour at room temperature with 5% (w/v) 
non-fat dried milk in TBS with 0.1% Tween 20. The membranes 
were  then  incubated  at  4°C  overnight  with  the  primary  anti-
bodies diluted in blocking solution: 2-Cys Prx (1:500, Abcam), 
Prx-SO2/3H (1:1,000, Abcam). For visualisation of western blots, 
HRP-based secondary antibodies were used followed by chemilu-
minescent detection on Kodak X-Omat film. Western blots were 
analysed by digitally scanning the blots, followed by densitometric 
analysis  (ImageJ).  All  analysis  of  Prx-SO2/3H  levels  involved 
normalizing to the loading control: total 2-Cys Prx as determined 
using an anti-2-Cys Prx antibody. Blots were first probed with 
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